Our TOPPODCAST Picks 
Stay ConnectedRational Evidence-Based Evaluation of Literature
- Home
- Top Charts
- Top Networks
- Top Apps
- Top Independents
- Top Podfluencers
- Top Picks
- Top Business Podcasts
- Top True Crime Podcasts
- Top Finance Podcasts
- Top Comedy Podcasts
- Top Music Podcasts
- Top Womens Podcasts
- Top Kids Podcasts
- Top Sports Podcasts
- Top News Podcasts
- Top Tech Podcasts
- Top Crypto Podcasts
- Top Entrepreneurial Podcasts
- Top Fantasy Sports Podcasts
- Top Political Podcasts
- Top Science Podcasts
- Top Self Help Podcasts
- Top Sports Betting Podcasts
- Top Stocks Podcasts
- Podcast News
- About Us
- Podcast Advertising
- Contact
In this episode, we're excited to continue collaboration with Arena Labs, where host Dr. Mark Ramzy interviews Allyn Abadie, Arena Labs’ Principal Scientist on how we can apply performance science in and out of the emergency department.
Consults aren’t a formality—they’re a patient-care intervention. In this post, Swami breaks down how to call a consult in the ED using a simple 4-step framework (introduce yourself, lead with the ask, give a focused summary, and close the loop), plus practical strategies for handling pushback, refusals, and when to escalate to protect patient care.
The RENOVATE trial set out to answer a high-impact question across five distinct etiologic groups: Is HFNC non-inferior to BPAP (NIV) for preventing intubation or death in acute respiratory failure?
Today we are exploring the imperative topic of rest and why it’s not just about sleeping. The first of a two part series, hosted by Dr. Mark Ramzy with guests Dr. Maureen Aiad and Dr. Amil Badoolah, our discussion sheds light on the multifaceted nature of rest, especially in the demanding field of emergency medicine. 
Corticosteroids have long sparked debate in the treatment of bacterial pneumonia — once viewed with skepticism, now increasingly supported by high-quality evidence. In this episode, Dr. Alex Chapa joins the REBEL Core Cast team to explore how the 2023 Cape Cod Trial (NEJM) reshaped practice and guideline recommendations for severe community-acquired pneumonia (CAP).
Host Dr. Mark Ramzy shines a spotlight on two phenomenal educators: Drs. Sara Crager and Ryan Ernst who shared their expertise and experiences at this transformative gathering last spring.
In this episode, we're excited to continue collaboration with Arena Labs, where host Dr. Marco Propersi interviews Jackie Pen, Heading of Performance Coaching at Arena Labs.
Welcome back to Rebel MIND, the podcast where we sharpen the person behind the practitioner. In this episode, hosted by Drs. Mark Ramzy and Marco Propersi, we're excited to introduce a collaboration with Arena Labs. Arena Labs is helping us measure healthcare performance through innovative programs designed to combat burnout and enhance personal wellness using data-driven strategies.
Non-invasive ventilation (NIV) refers to respiratory support provided without endotracheal intubation. The most common modalities include continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), and high-flow nasal cannula (HFNC). These therapies aim to improve oxygenation, reduce the work of breathing, and potentially prevent invasive mechanical ventilation.
Etomidate or ketamine? The debate over the ideal agent for emergency rapid sequence intubation (RSI) has raged for years with no clear winner. Etomidate has been touted in the past for its rapid onset and minimal intrinsic effects on hemodynamics. However, the drug is well known as a transient adrenal suppressant though the impact of this suppression isn’t clear. Ketamine has risen in recent years as an alternative, due to its perceived hemodynamic stability, analgesic properties and absence of adrenal suppression. Additionally, recent data points towards improved mortality when ketamine was selected over etomidate (Kotani 2023). High quality randomized controlled trials are needed to further elucidate which agent should be selected in critically ill patients.
